Immuron (IMRN) Revenue (2016 - 2024)
Immuron's (IMRN) quarterly Revenue came in at -$7958490935.5 billion in Q4 2024, down 337856958181987.6% year-on-year from N/an in Q1 2024, and down 337856958181987.6% quarter-over-quarter from $2.4 million in Q4 2023.
Immuron (IMRN) Revenue (2016 - 2024) Analysis & Trends
Immuron's Revenue history runs 9 years deep, the most recent figure standing at -$7958490935.5 billion for Q4 2024.
- On a quarterly basis, Revenue fell 337856958181987.6% year-over-year to -$7958490935.5 billion in Q4 2024; TTM through Dec 2024 was -$7958490935.5 billion, a 263189891376702.1% decrease from a year earlier, with the FY2025 full-year figure at $4.7 million, up 46.88% from the prior year.
- Revenue slipped to -$7958490935.5 billion in Q4 2024 per IMRN's latest filing, from $2.4 million in the prior quarter.
- Across five years, Revenue topped out at $2.4 million in Q4 2023 and bottomed at -$7958490935.5 billion in Q4 2024.
- The 5-year median for Revenue is $42316.4 (2021), against an average of -$1326415155.9 billion.
- Across the five-year window, Revenue jumped 11389249.91% in 2021 and sank 337856958181987.6% in 2024, its largest moves.
- Year by year, Revenue stood at $0.01 in 2020, then soared by 11389249.91% to $1690.7 in 2021, then soared by 34421.0% to $583646.0 in 2022, then soared by 303.6% to $2.4 million in 2023, then sank by 337856958181987.6% to -$7958490935.5 billion in 2024.
- Per Business Quant, the three latest IMRN Revenue figures stand at -$7958490935.5 billion (Q4 2024), $2.4 million (Q4 2023), and $82942.2 (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Immuron | 255.19 Mn | 243.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -7,958,490,935.54 Bn |
| Dec 31, 2023 | 2.36 Mn |
| Jun 30, 2023 | 82,942.19 |
| Dec 31, 2022 | 583,646.00 |
| Dec 31, 2021 | 1,690.70 |
| Dec 31, 2020 | 0.01 |
| Dec 31, 2019 | 2.39 Mn |
| Dec 31, 2018 | 978,233.00 |
| Dec 31, 2017 | 716,323.37 |
| Dec 31, 2016 | 530,121.20 |
| Jun 30, 2016 | 862,831.81 |